Hagir B. Suliman mainly investigates Mitochondrial biogenesis, Mitochondrion, Molecular biology, Oxidative phosphorylation and Heme oxygenase. Hagir B. Suliman focuses mostly in the field of Mitochondrial biogenesis, narrowing it down to matters related to Intensive care and, in some cases, Mitochondrial Size. His Mitochondrion study combines topics from a wide range of disciplines, such as Internal medicine, Endothelial NOS and Endocrinology.
His study looks at the relationship between Molecular biology and fields such as NRF1, as well as how they intersect with chemical problems. His Oxidative phosphorylation research includes themes of Oxidative stress and TFAM. His study on HMOX1 is often connected to Doxorubicin as part of broader study in Heme oxygenase.
Hagir B. Suliman spends much of his time researching Mitochondrial biogenesis, Mitochondrion, Molecular biology, Cell biology and Oxidative stress. Hagir B. Suliman focuses mostly in the field of Mitochondrial biogenesis, narrowing it down to topics relating to Heme oxygenase and, in certain cases, Hemeprotein. The concepts of his Mitochondrion study are interwoven with issues in Endocrinology, Internal medicine, SOD2 and Pathology.
His Molecular biology research is multidisciplinary, incorporating elements of NFKB1, Promoter, Lung injury and Toll-like receptor. His Cell biology research is multidisciplinary, incorporating perspectives in Inflammation, mitochondrial fusion, Cell damage and Mitophagy. Hagir B. Suliman works mostly in the field of Oxidative stress, limiting it down to concerns involving Oxidative phosphorylation and, occasionally, Glutathione and Cytochrome c oxidase.
Hagir B. Suliman mainly focuses on Mitochondrial biogenesis, Mitochondrion, Sepsis, Molecular biology and Cell biology. His Mitochondrial biogenesis study focuses on TFAM in particular. His work in TFAM covers topics such as NRF1 which are related to areas like Tumor necrosis factor alpha, Andrology and Heme oxygenase.
His Mitochondrion study introduces a deeper knowledge of Biochemistry. Hagir B. Suliman combines subjects such as Dialysis, Lung injury, Lung and Immunohistochemistry with his study of Sepsis. His Cell biology study combines topics from a wide range of disciplines, such as mitochondrial fusion, Oxidative stress and Mitophagy.
His primary scientific interests are in Mitochondrial biogenesis, Mitochondrion, Cell biology, Mitophagy and Molecular biology. Mitochondrial biogenesis is a subfield of Biochemistry that Hagir B. Suliman studies. His Biochemistry research includes elements of Reperfusion injury and NFE2L2.
His research in Cell biology intersects with topics in mitochondrial fusion and Oxidative stress. His study looks at the relationship between Molecular biology and topics such as TFAM, which overlap with NRF1, FIS1 and Mitochondrial fission. Hagir B. Suliman works mostly in the field of Autophagy, limiting it down to topics relating to Programmed cell death and, in certain cases, HMOX1, Cardiac fibrosis, Autophagosome, Lung injury and Bronchoalveolar lavage.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1
Claude A. Piantadosi;Martha Sue Carraway;Abdelwahid Babiker;Hagir B. Suliman.
Circulation Research (2008)
Survival in critical illness is associated with early activation of mitochondrial biogenesis.
Jane E. Carré;Jean Christophe Orban;Lorenza Re;Karen Felsmann.
American Journal of Respiratory and Critical Care Medicine (2010)
EXTRACELLULAR SUPEROXIDE DISMUTASE IN THE AIRWAYS OF TRANSGENIC MICE REDUCES INFLAMMATION AND ATTENUATES LUNG TOXICITY FOLLOWING HYPEROXIA
Rodney J. Folz;Amir M. Abushamaa;Hagir B. Suliman.
Journal of Clinical Investigation (1999)
Extracellular superoxide dismutase.
Eva Nozik-Grayck;Hagir B. Suliman;Claude A. Piantadosi.
The International Journal of Biochemistry & Cell Biology (2005)
Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis
Hagir B. Suliman;Karen E. Welty-Wolf;Martha Sue Carraway;Lynn Tatro.
Cardiovascular Research (2004)
The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy
Hagir B. Suliman;Martha Sue Carraway;Abdelwahid S. Ali;Chrystal M. Reynolds.
Journal of Clinical Investigation (2007)
Mitochondrial transcription factor-A induction by redox activation of nuclear respiratory factor-1
Claude A. Piantadosi;Hagir B. Suliman.
Journal of Biological Chemistry (2006)
Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression *
Claude A. Piantadosi;Crystal M. Withers;Raquel R. Bartz;Nancy Chou MacGarvey.
Journal of Biological Chemistry (2011)
Mitochondrial Quality Control as a Therapeutic Target
Hagir B. Suliman;Claude A. Piantadosi.
Pharmacological Reviews (2016)
Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1.
Hagir B. Suliman;Martha S. Carraway;Karen E. Welty-Wolf;A.Richard Whorton.
Journal of Biological Chemistry (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Duke University
University of Pittsburgh
Tokyo Metropolitan Institute of Medical Science
University of Colorado Anschutz Medical Campus
University College London
TU Dresden
University of California, San Francisco
Duke University
University of Alabama at Birmingham
University Hospitals of Cleveland
University of Shanghai for Science and Technology
Inha University
Chinese Academy of Sciences
University of Montreal
Guangdong University of Technology
Kyoto University
Shinshu University
University Medical Center Groningen
University of Washington
University of Helsinki
University at Albany, State University of New York
University of Sydney
Oregon Health & Science University
European Institute of Oncology
University of Warwick
University of Zurich